NCT01061801
- Conditions
- Cancer, Hematopoietic Stem Cell Transplantation, Neoplasms
- Locations
-
- Fred Hutchinson Cancer Research Center Seattle, Washington, United States
Clinical trial condition
Neoplasms
Explore clinical trials studying Neoplasms. Study availability and eligibility vary by location and protocol.
7,940 public trials
1,514 recruiting studies
Neoplasms trial results
NCT00492830
- Conditions
- Cancer, Neoplasm Metastasis, Neoplasms, +3 more
- Locations
-
- Birmingham, Alabama, United States
- Phoenix, Arizona, United States
- Santa Monica, California, United States
NCT00600444
- Conditions
- Cancer, Hyperphagia, Neoplasms, +3 more
- Locations
-
- University of Heidelberg Heidelberg, Baden Würtemberg, Germany
NCT00589823
- Conditions
- Cancers, Pain, Neoplasms, Neurologic Manifestations, +3 more
- Locations
-
- Prof Fallon Edinburgh, United Kingdom
NCT00613743
- Conditions
- Cancer, Digestive System Diseases, Gastroenteritis, +5 more
- Locations
-
- University Hospital Geneva Geneva, Collonge-bellerive, Switzerland
NCT00758407
- Conditions
- Cancer-related Fatigue, Fatigue, Neoplasms, +2 more
- Locations
-
- Sonnenbergklinik Bad Sooden-Allendorf, Germany
- Dr. J.-U. Rüffer Cologne, Germany
- Praxis Dr. Lathan Dortmund, Germany
- Praxis Dr. Verpoort - Dr. Zeller Hamburg, Germany
Completed
Rasburicase Versus Allopurinol in Tumor Patients at Risk for Hyperuricemia and Tumor Lysis Syndrome
NCT00230178
- Conditions
- Bone Marrow Diseases, Cancer, Hematologic Diseases, +14 more
- Locations
-
- Alta Bates Comprehensive Cancer Center Berkeley, California, United States
- UCLA Medical Center Los Angeles, California, United States
- Rocky Mountain Cancer Center Denver, Colorado, United States
- University of Florida Health Science Center at Jacksonville Jacksonville, Florida, United States
NCT00249977
- Conditions
- Cancer, Neoplasms, Solid Tumors
- Locations
-
- University of New Mexico Albuquerque, New Mexico, United States
NCT00277069
- Conditions
- Breast, Cancer, Neoplasms
- Locations
-
- University of New Mexico Albuquerque, New Mexico, United States
Completed
INST Phase II Trial of Gemcitabine and Irinotecan in Patients With Relapsed or Refractory Lymphoma.
NCT00276003
- Conditions
- Cancer, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
- Locations
-
- Lovelace Sandia Health Systems Dept of Hematology Albuquerque, New Mexico, United States
- University of New Mexico Albuquerque, New Mexico, United States